Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.
about
Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infectionsRegulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and VaccinationAsymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studiesPlasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites.Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36.Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania majorCutaneous Manifestations of Human and Murine LeishmaniasisThe immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species.Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis.Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy.T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis.Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.Immunological perspectives of leishmaniasis.Cell biology and immunology of Leishmania.Pathways towards an effective immunotherapy for Parkinson's diseaseInflammation and adaptive immunity in Parkinson's disease.Protective immunity and vaccination against cutaneous leishmaniasis.Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease.Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major.Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens.Comparison of clinical samples and methods in chronic cutaneous leishmaniasis.Expression of Foxp3, TGF-β and IL-10 in American cutaneous leishmaniasis lesions.Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis.Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients.Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis.Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.Evaluation of Regulatory Immune Response in Skin Lesions of Patients Affected by Nonulcerated or Atypical Cutaneous Leishmaniasis in Honduras, Central America.Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis
P2860
Q26850457-6AB575B0-A680-4B1C-91C1-911A2BE51B96Q28081492-1E17D443-DE23-4341-87FA-890A543D1907Q30244323-67605777-4F28-4383-8A01-CE35DD7A209BQ33540173-0CE44382-EC43-468F-A0C8-BAF56256C90BQ33778936-D025D0FD-B704-4E21-B1FD-0A1AFC6EAD70Q33833263-6624933F-2646-4CD7-B67B-1A6AAB37C33DQ33839048-4D5783DB-E53C-4B88-9FBD-73CF19F989CFQ34219774-FC0E0684-2B38-402F-9F5D-2C43AA10F04BQ34251387-FF8D59C0-3FEB-4C6D-853A-C0FC4CC29399Q34772767-27EBA52D-13A8-40C4-88AD-17DDF997FAD9Q34871440-EAB7BD73-8343-43CE-A6CE-1808D164B33EQ35139231-50997DD3-10FC-4BF3-8D70-8B48C8EBBA0EQ35806436-65F1CBA8-1C74-4651-9C2F-5A2C1F306156Q35826141-007D7D66-6A1D-446E-9902-9FED19C6C47CQ35845442-5734847E-D99F-445F-B5BC-EBB925F38BBFQ35910599-6F530E8A-14B9-48DB-BB6D-24B2ADBF2213Q35928348-CDE65B77-2ACF-48C2-806C-4820D29182EDQ36141241-AC9E0AB2-3F38-46FF-93B3-E1A4B9C8A6B5Q36311439-075D6376-F71A-4159-9509-5FAD26DD78C8Q37522460-93F81907-1F59-46B2-A2ED-51D32430F8B7Q37770420-FE2E1B57-E192-4CA1-A531-55F8C12E1227Q37846878-75FF7C04-521C-438A-878B-3E39B3D9C6C4Q37957125-98AF890D-2F54-4E56-BC69-5921F3503A93Q37982378-951D58C2-FDBD-4945-842E-95D1BF406265Q38015852-EC824921-719E-4C7B-BBA4-BB21F9FB5605Q38061723-FA28145C-89B8-40F9-94E9-43A3426AEBE3Q39644235-7353C28E-D771-4BA5-8596-FB9D7C266D23Q40038032-FE5C5E9A-6D27-4D32-86AC-CB65B9177ABCQ40722535-C0DF459A-7CB9-4ED2-AEE8-374E868BDC4DQ40939652-A0D32A4B-6FA2-421D-8BD2-E6E601F7C5F4Q41856326-F7815090-9589-4D1A-9196-AB2924A31B01Q42070552-1BEDA463-8960-4096-9B25-6D13D8817932Q42252111-713333CC-3ED9-47C8-AA0E-26DE2B38B3AFQ42274853-ECB28F4D-0C9D-4F8B-8705-4FB07009F568Q45813783-741096CB-A3CA-411D-8AE0-08117FC4491DQ46247986-B22665B3-7024-4B9D-8CCE-CC8D971D2F28Q50192356-B328F875-77ED-4ED7-84F1-3C53364B37A7Q54216568-622CFF97-FD61-4C1D-B8F6-7178E1F007F7Q56895331-C688C947-1B59-4A0E-B16D-4197422873EF
P2860
Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@en
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@nl
type
label
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@en
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@nl
prefLabel
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@en
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@nl
P2093
P2860
P356
P1476
Intralesional regulatory T-cel ...... due to Leishmania guyanensis.
@en
P2093
D Sainte Marie
E Bourreau
E Darcissac
P2860
P304
P356
10.1128/IAI.01398-08
P407
P577
2009-01-21T00:00:00Z